BioCentury
ARTICLE | Distillery Techniques

Techniques: Leukemia inhibitory factor receptor α (LIFR; CD118)-knockdown mouse model of osteolytic bone metastases of breast cancer

October 6, 2016 7:00 AM UTC

An LIFR-knockdown mouse model of metastatic breast cancer could be useful for screening therapies to treat osteolytic bone metastases of the cancer. In a xenograft mouse model of metastatic breast can...